DEFA14A: Amgen Urges Stockholders to Vote Ahead of Annual Meeting

Amgen is reminding stockholders to vote on key proposals ahead of the Annual Meeting of Stockholders scheduled for May 31, 2024.

Summary

• Amgen is urging its stockholders to vote their shares in connection with the upcoming Annual Meeting of Stockholders to be held on May 31, 2024.
• The company notes that according to their latest records, some stockholders have not yet submitted their vote instructions.
• The Board of Directors recommends voting FOR each director nominee, the advisory vote to approve executive compensation, the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, and the ratification of Ernst & Young LLP as the independent registered public accountants.
• Stockholders can vote by telephone or online until 11:59 P.M. Eastern Time on May 28, 2024, for shares held in plans sponsored by Amgen or its subsidiaries, and by 11:59 P.M. Eastern Time on May 30, 2024, for shares held directly.

Sentiment

Score: 7

Explanation: The document is a standard communication encouraging shareholder participation, so the sentiment is neutral to slightly positive due to the proactive engagement.

Positives

• The company is actively encouraging stockholder participation in the voting process.
• Clear recommendations are provided by the Board of Directors on how to vote on each item.

Future Outlook

The document focuses on the immediate action of voting for the upcoming annual meeting and does not contain forward-looking statements about future financial performance or strategic direction.

Management Comments

• The Board of Directors recommends that you vote FOR each director nominee.
• The Board of Directors recommends that you vote FOR the advisory vote to approve our executive compensation.
• The Board of Directors recommends that you vote FOR our Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.
• The Board of Directors recommends that you vote FOR the ratification of Ernst & Young LLP as our independent registered public accountants.

Industry Context

This announcement is a standard corporate communication related to the annual meeting, a routine event for publicly traded companies like Amgen. It ensures compliance with regulations and promotes shareholder engagement.

Stakeholder Impact

• Shareholders are directly impacted as they are being asked to vote on important company matters.
• The outcome of the votes will influence the company's governance and direction.

Next Steps

• Stockholders need to vote on the listed proposals before the deadlines.
• Amgen will hold its Annual Meeting of Stockholders on May 31, 2024.

Key Dates

Keywords

Amgen, stockholders, proxy vote, annual meeting, board of directors, executive compensation, equity incentive plan, Ernst & Young, voting, shares